Valuation Indivior Pharmaceuticals, Inc. Xetra

Stocks

Market Closed - Xetra Other stock markets 11:35:59 2026-07-17 EDT			After hours 15:22:27
35.60 ^EUR	0.00%		35.50	-0.28%

06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index	CI
06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,949	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	10.47%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	5,003	4,545	4,021
Change	-	55.81%	-17.52%	-21.95%	193.72%	8.68%	-9.15%	-11.54%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	12.8x	11.2x	10.4x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0.1x	0.8x	1.29x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.93x	3.78x	3.6x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.98x	3.48x	2.93x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	7.66x	6.58x	5.6x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	8.03x	6.85x	5.75x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	13.9x	9.38x	7.47x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	7.2%	10.7%	13.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.175	3.61	3.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,258	1,308	1,374
EBITDA ¹	202	225	288	338	428	652.9	690.5	718.4
EBIT ¹	187	212	269	312	415	623.3	664	698.8
Net income ¹	205	-53	2	-48	210	414.5	472.9	517.4
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	40.59	40.59	40.59
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	121,922	-	-
Announcement Date	2/16/22	2/16/23	2/22/24	2/20/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.75x	12.42x	25.87x	0.58%	1,043B
JOHNSON & JOHNSON	26.86x	6.13x	16.78x	2.15%	602B
ABBVIE INC.	33.14x	7.52x	15.43x	2.7%	449B
ROCHE HOLDING AG	17.71x	4.39x	10.82x	3.02%	327B
NOVARTIS AG	21.31x	5.47x	13.24x	2.89%	279B
ASTRAZENECA PLC	21.26x	4.48x	12.39x	1.96%	264B
AMGEN INC.	24.37x	6.42x	11.35x	2.71%	201B
GILEAD SCIENCES, INC.	-49.1x	5.86x	32.41x	2.38%	169B
PFIZER INC.	12.77x	3.12x	7.88x	6.86%	143B
Average	15.90x	6.20x	16.24x	2.81%	386.34B
Weighted average by Cap.	23.88x	7.73x	18.23x	2.11%